Our Mission
We are dedicated to saving lives in critical environments with our revolutionary blood substitute in development. Join us in transforming trauma care.
About VivoBlood
At ReGen Factor, we are pioneering advanced biomedical solutions aimed at helping people live longer, healthier lives. Our focus is on safe, synthetic blood replacement technologies that support critical care, chronic disease treatment, and global blood supply resilience. Recent developments by Atos Labs and similar innovators in bioengineered fluids and oxygen carriers highlight a growing shift toward artificial blood as a vital component of future medicine. These breakthroughs validate the need for scalable, pathogen-free, and immune-compatible alternatives to human blood. VivoBlood fits into this movement with our proprietary, next-generation product—VivoBlood—being designed for superior oxygen delivery, immune safety, and trauma readiness. Our work supports both civilian healthcare and defense medicine, redefining what’s possible in transfusion science.
Trauma Care with VivoBlood
VivoBlood is a revolutionary blood substitute being developed to transform trauma care in critical environments. Our mission is to save lives in extreme conditions by providing a safe, stable, and effective alternative to conventional blood transfusions. We focus on enhancing survival outcomes for soldiers and trauma patients.
ReGen Factor is at the forefront of innovation with our revolutionary blood substitute in development, meticulously designed to transform trauma care in critical environments such as battlefields and emergency situations. Our primary objective is to engage investors, medical professionals, and military partners by highlighting the groundbreaking technology, significant market potential, and proven product efficacy, all while underscoring our mission to save lives in extreme conditions. Committed to enhancing survival outcomes for soldiers and trauma patients, VivoBlood aims to be a safe, stable, and effective alternative to conventional blood transfusions.